Company Filing History:
Years Active: 2016
Title: George H. Lowell: Innovator in Influenza Vaccine Development
Introduction
George H. Lowell is a notable inventor based in Jerusalem, IL. He has made significant contributions to the field of immunology, particularly in the development of vaccines against influenza. His innovative approach focuses on enhancing the efficacy of seasonal and pandemic influenza vaccines.
Latest Patents
George H. Lowell holds a patent for "Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines." This invention relates to the use of multimeric multi-epitope peptide-based compositions for immunizing subjects against influenza. The compositions can be administered to subjects prior to or alongside seasonal or pandemic influenza vaccines. This advancement aims to improve the overall effectiveness of influenza immunization.
Career Highlights
George H. Lowell is associated with Biondvax Pharmaceuticals Ltd., a company dedicated to developing innovative solutions for infectious diseases. His work at Biondvax has positioned him as a key player in the field of vaccine research and development.
Collaborations
George collaborates with Tamar Ben-Yedidia, who is also involved in the research and development of vaccines. Their partnership exemplifies the collaborative spirit necessary for advancing medical innovations.
Conclusion
George H. Lowell's contributions to influenza vaccine development highlight the importance of innovation in public health. His work continues to pave the way for more effective immunization strategies against influenza.